EBV the prototypical human tumor virus - Just how bad is it?

Journal of Allergy and Clinical Immunology

Volumn 116, Issue 2, 2005, Pages 251-261

  Thorley Lawson, David A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B cell; Carcinoma; Epstein Barr virus; Latency; Lymphoma; Memory; Persistent infection

Indexed keywords

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BURKITT LYMPHOMA; BYSTANDER EFFECT; CANCER RISK; CARCINOGENESIS; CARCINOMA; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENE EXPRESSION; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOBLASTIC LYMPHOMA; LYMPHOMA; MEMORY CELL; NASOPHARYNX CARCINOMA; NONHUMAN; ONCOGENE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TUMOR IMMUNITY; VIRUS INFECTION; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TRANSCRIPTION;

BURKITT LYMPHOMA; EPITHELIUM; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOMA; NASOPHARYNGEAL NEOPLASMS; VIRUS SHEDDING;

EID: 23244448471     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.05.038     Document Type: Review

References (85)

1. A.B. Rickinson, and E. Kieff Epstein-Barr virus D.M. Knipe P.M. Howley Virology 4th ed. 2001 Lippincott Williams and Wilkins New York 2575 2628
2. E. Kieff, and A.B. Rickinson Epstein-Barr virus and its replication D.M. Knipe P.M. Howley Virology 4th ed. 2001 Lippincott Williams and Wilkins New York 2511 2574
3. D.A. Thorley-Lawson Epstein-Barr virus H. Cantor Sampter's immunologic diseases 2001 Williams and Wilkins New York 970 985
4. W. Henle, and G. Henle Seroepidemiology of the virus M.A. Epstein B.G. Achong The Epstein-Barr virus 1979 Springer-Verlag Berlin 61 78
5. J.H. Pope, M.K. Horne, and W. Scott Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus Int J Cancer 3 1968 857 866
6. W. Henle, V. Diehl, G. Kohn, H. Zur Hausen, and G. Henle Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells Science 157 1967 1064 1065
7. T.A. Seemayer, T.G. Gross, R.M. Egeler, S.J. Pirruccello, J.R. Davis, and C.M. Kelly X-linked lymphoproliferative disease: twenty-five years after the discovery Pediatr Res 38 1995 471 478
8. A.J. Coffey, R.A. Brooksbank, O. Brandau, T. Oohashi, G.R. Howell, and J.M. Bye Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene Nat Genet 20 1998 129 135
9. J. Sayos, C. Wu, M. Morra, N. Wang, X. Zhang, and D. Allen The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM Nature 395 1998 462 469
10. P. Hopwood, and D.H. Crawford The role of EBV in post-transplant malignancies: a review J Clin Pathol 53 2000 248 254
11. G. Khan, E.M. Miyashita, B. Yang, G.J. Babcock, and D.A. Thorley-Lawson Is EBV persistence in vivo a model for B cell homeostasis? Immunity 5 1996 173 179
12. G.J. Babcock, L.L. Decker, R.B. Freeman, and D.A. Thorley-Lawson Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients J Exp Med 190 1999 567 576
13. D.A. Thorley-Lawson, and A. Gross Persistence of the Epstein-Barr virus and the origins of associated lymphomas N Engl J Med 350 2004 1328 1337
14. D.A. Thorley-Lawson Epstein-Barr virus: exploiting the immune system Nat Rev Immunol 1 2001 75 82
15. E.M. Miyashita, B. Yang, G.J. Babcock, and D.A. Thorley-Lawson Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell J Virol 71 1997 4882 4891
16. G.J. Babcock, L.L. Decker, M. Volk, and D.A. Thorley-Lawson EBV persistence in memory B cells in vivo Immunity 9 1998 395 404
17. D. Hochberg, J.M. Middeldorp, M. Catalina, J.L. Sullivan, K. Luzuriaga, and D.A. Thorley-Lawson Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo Proc Natl Acad Sci U S A 101 2003 239 244
18. P. Brandtzaeg, I.N. Farstad, and G. Haraldsen Regional specialization in the mucosal immune system: primed cells do not always home along the same track Immunol Today 20 1999 267 277
19. M. Perry, and A. Whyte Immunology of the tonsils Immunol Today 19 1998 414 421
20. Y.J. Liu, and C. Arpin Germinal center development Immunol Rev 156 1997 111 126
21. A.M. Joseph, G.J. Babcock, and D.A. Thorley-Lawson Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils J Virol 74 2000 9964 9971
22. G.J. Babcock, D. Hochberg, and A.D. Thorley-Lawson The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell Immunity 13 2000 497 506
23. S. Casola, K.L. Otipoby, M. Alimzhanov, S. Humme, N. Uyttersprot, and J.L. Kutok B cell receptor signal strength determines B cell fate Nat Immunol 5 2004 317 327
24. B. He, N. Raab-Traub, P. Casali, and A. Cerutti EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching J Immunol 171 2003 5215 5224
25. D. Panagopoulos, P. Victoratos, M. Alexiou, G. Kollias, and G. Mosialos Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo J Virol 78 2004 13253 13261
26. K.L. Calame, K.I. Lin, and C. Tunyaplin Regulatory mechanisms that determine the development and function of plasma cells Annu Rev Immunol 21 2003 205 230
27. J. Uchida, T. Yasui, Y. Takaoka-Shichijo, M. Muraoka, W. Kulwichit, and N. Raab-Traub Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses Science 286 1999 300 303
28. D. Hochberg, T. Souza, M. Catalina, J.L. Sullivan, K. Luzuriaga, and D.A. Thorley-Lawson Acute infection with Epstein-Bar virus targets and overwhelms the peripheral memory B cell compartment with resting, latently infected cells J Virol 78 2004 5194 5204
29. J.L. Yates, N. Warren, and B. Sugden Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells Nature 313 1985 812 815
30. J. Levitskaya, M. Coram, V. Levitsky, S. Imreh, M.P. Steigerwald, and G. Klein Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1 Nature 375 1995 685 688
31. L.L. Laichalk, and D.A. Thorley-Lawson Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo J Virol 79 2005 1296 1307
32. P. Brandtzaeg, E.S. Baekkevold, I.N. Farstad, F.L. Jahnsen, F.E. Johansen, and E.M. Nilsen Regional specialization in the mucosal immune system: what happens in the microcompartments? Immunol Today 20 1999 141 151
33. H.D. Golden, R.S. Chang, W. Prescott, E. Simpson, and T.Y. Cooper Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals J Infect Dis 127 1973 471 473
34. M. Andersson-Anvret, N. Forsby, G. Klein, and W. Henle Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination Int J Cancer 20 1977 486 494
35. D. Shibata, and L.M. Weiss Epstein-Barr virus-associated gastric adenocarcinoma Am J Pathol 140 1992 769 774
36. J.S. Greenspan, D. Greenspan, E.T. Lennette, D.I. Abrams, M.A. Conant, and V. Petersen Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion N Engl J Med 313 1985 1564 1571
37. M.A. Karajannis, M. Hummel, I. Anagnostopoulos, and H. Stein Strict lymphotropism of Epstein-Barr virus during acute infectious mononucleosis in nonimmunocompromised individuals Blood 89 1997 2856 2862
38. S.M. Tugizov, J.W. Berline, and J.M. Palefsky Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells Nat Med 9 2003 307 314
39. D.M. Pegtel, J. Middeldorp, and D.A. Thorley-Lawson Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers J Virol 78 2004 12613 12624
40. J.W. Gratama, M.A. Oosterveer, F.E. Zwaan, J. Lepoutre, G. Klein, and I. Ernberg Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency Proc Natl Acad Sci U S A 85 1988 8693 8696
41. G.C. Faulkner, S.R. Burrows, R. Khanna, D.J. Moss, A.G. Bird, and D.H. Crawford X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus J Virol 73 1999 1555 1564
42. L.L. Laichalk, and D.A. Thorley-Lawson Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo J Virol 79 2005 1296 1307
43. R. Khanna, D.J. Moss, and S.R. Burrows Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation Immunol Rev 170 1999 49 64
44. R. Khanna, R.W. Slade, L. Poulsen, D.J. Moss, S.R. Burrows, and J. Nicholls Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift J Virol 71 1997 8340 8346
45. R.E. Phillips, S. Rowland-Jones, D.F. Nixon, F.M. Gotch, J.P. Edwards, and A.O. Ogunlesi Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition Nature 354 1991 453 459
46. J. Kurth, T. Spieker, J. Wustrow, G.J. Strickler, L.M. Hansmann, and K. Rajewsky EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency Immunity 13 2000 485 495
47. J. Kurth, A. Perniok, R. Schmitz, C. Iking-Konert, N. Chiorazzi, and K.M. Thompson Lack of deleterious somatic mutations in the CD95 gene of plasmablasts from systemic lupus erythematosus patients and autoantibody-producing cell lines Eur J Immunol 32 2002 3785 3792
48. C. Arpin, J. Dechanet, K.C. Van, P. Merville, G. Grouard, and F. Briere Generation of memory B cells and plasma cells in vitro Science 268 1995 720 722
49. C. Arpin, J. Banchereau, and Y.J. Liu Memory B cells are biased towards terminal differentiation: a strategy that may prevent repertoire freezing J Exp Med 186 1997 931 940
50. J.A. Thomas, N.A. Hotchin, M.J. Allday, P. Amlot, M. Rose, and M. Yacoub Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals Transplantation 49 1990 944 953
51. J. Kurth, M.L. Hansmann, K. Rajewsky, and R. Kuppers Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction Proc Natl Acad Sci U S A 100 2003 4730 4735
52. J.M. Timms, A. Bell, J.R. Flavell, P.G. Murray, A.B. Rickinson, and A. Traverse-Glehen Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma Lancet 361 2003 217 223
53. S.L. Glaser, R.J. Lin, S.L. Stewart, R.F. Ambinder, R.F. Jarrett, and P. Brousset Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data Int J Cancer 70 1997 375 382
54. S.L. Glaser, C.A. Clarke, M.L. Gulley, F.E. Craig, J.A. DiGiuseppe, and R.F. Dorfman Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998 Cancer 98 2003 300 309
55. J.J. Oudejans, D.F. Dukers, N.M. Jiwa, A.J. van den Brule, F.A. Grasser, and P.C. de Bruin Expression of Epstein-Barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV J Clin Pathol 49 1996 897 902
56. E.M. Deacon, G. Pallesen, G. Niedobitek, J. Crocker, L. Brooks, and A.B. Rickinson Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells J Exp Med 177 1993 339 349
57. H. Herbst, F. Dallenbach, M. Hummel, G. Niedobitek, S. Pileri, and L.N. Muller Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells Proc Natl Acad Sci U S A 88 1991 4766 4770
58. G. Niedobitek, E. Kremmer, H. Herbst, L. Whitehead, C.W. Dawson, and E. Niedobitek Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis Blood 90 1997 1664 1672
59. G. Mosialos, M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family Cell 80 1995 389 399
60. O. Gires, U. Zimber-Strobl, R. Gonnella, M. Ueffing, G. Marschall, and R. Zeidler Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule EMBO J 16 1997 6131 6140
61. R.G. Caldwell, J.B. Wilson, S.J. Anderson, and R. Longnecker Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals Immunity 9 1998 405 411
62. D. Wang, D. Liebowitz, and E. Kieff An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells Cell 43 1985 831 840
63. D.A. Thorley-Lawson Epstein-Barr virus K.F. Austen M.M. Frank J.P. Atkinson H. Cantor Sampter's immunologic diseases 6th ed. 2001 Williams and Wilkins New York 970 985
64. R. Kuppers, and K. Rajewsky The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease Annu Rev Immunol 16 1998 471 493
65. M.A. Epstein, B.G. Achong, and Y.M. Barr Virus particles in cultured lymphoblasts from Burkitt's lymphoma Lancet 1 1964 702 703
66. G. de-The Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited G.M. Lenoir G.T. O'Conor C.L.M. Olweny Burkitt's lymphoma: a human cancer model 1985 Oxford University Press New York 165 176
67. M.L. Gulley, M. Raphael, C.T. Lutz, D.W. Ross, and N. Raab-Traub Epstein-Barr virus integration in human lymphomas and lymphoid cell lines Cancer 70 1992 185 191
68. C.D. Gregory, M. Rowe, and A.B. Rickinson Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line J Gen Virol 71 1990 1481 1495
69. J.B. Wilson, J.L. Bell, and A.J. Levine Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice EMBO J 15 1996 3117 3126
70. K. Takada, and A. Nanbo The role of EBERs in oncogenesis Semin Cancer Biol 11 2001 461 467
71. G.M. Lenoir, and G.W. Bornkamm Burkitt lymphoma a human cancer model for the study of the multistep development of cancer: a new scenario G. Klein Advances in viral oncology 1987 Raven Press New York 173 206
72. G. Klein In defense of the "old" Burkitt lymphoma scenario G. Klein Advances in viral oncology 1987 Raven Press New York 207 211
73. G. Kelly, A. Bell, and A. Rickinson Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2 Nat Med 8 2002 1098 1104
74. H.H. Niller, D. Salamon, F. Banati, F. Schwarzmann, H. Wolf, and J. Minarovits The LCR of EBV makes Burkitt's lymphoma endemic Trends Microbiol 12 2004 495 499
75. G. de The The etiology of Burkitt's lymphoma and the history of the shaken dogmas Blood Cells 19 1993 667 675
76. D. Burkitt A lymphoma syndrome in African children Ann R Coll Surg Engl 30 1962 211 219
77. U. Klein, G. Klein, B. Ehlin-Henriksson, K. Rajewsky, and R. Kuppers Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes Mol Med 1 1995 495 505
78. C.D. Gregory, T. Tursz, C.F. Edwards, C. Tetaud, M. Talbot, and B. Caillou Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype J Immunol 139 1987 313 318
79. M.C. Yu, and J.M. Yuan Epidemiology of nasopharyngeal carcinoma Semin Cancer Biol 12 2002 421 429
80. N. Raab-Traub, and K. Flynn The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation Cell 47 1986 883 889
81. L. Brooks, Q.Y. Yao, A.B. Rickinson, and L.S. Young Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts J Virol 66 1992 2689 2697
82. R. Fahraeus, H.L. Fu, I. Ernberg, J. Finke, M. Rowe, and G. Klein Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma Int J Cancer 42 1988 329 338
83. L.S. Young, C.W. Dawson, D. Clark, H. Rupani, P. Busson, and T. Tursz Epstein-Barr virus gene expression in nasopharyngeal carcinoma J Gen Virol 69 1988 1051 1065
84. R. Pathmanathan, U. Prasad, R. Sadler, K. Flynn, and N. Raab-Traub Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma [see comments] N Engl J Med 333 1995 693 698
85. S. Gottschalk, H.E. Heslop, and C.M. Rooney Adoptive immunotherapy for EBV-associated malignancies Leuk Lymphoma 46 2005 1 10